Literature DB >> 7832634

Antibody to HIV-1 Tat protein inhibits the replication of virus in culture.

L Steinaa1, A M Sørensen, J O Nielsen, J E Hansen.   

Abstract

The HIV-1 transactivator protein Tat is essential for viral replication. Tat is released from infected cells and can be taken up and transactivate HIV-LTR in LTR-CAT transfected cell lines. The present study shows that the addition of monoclonal antibody to Tat in IIIB and MN-infected cultures reduces the HIV antigen production in a concentration dependent manner. These data suggest that external Tat might be important in the replication of HIV, exerting the effect in a paracrine fashion. Using 1 microgram/ml of anti-Tat antibody resulted in a decline of HIV antigen production to 33% and 45% of controls in IIIB and MN infected H9 cells, respectively. A time course experiment showed progressively increased inhibition of replication during 7 days of exposure to anti-Tat antibody, which could be due to increasing Tat concentration. The inhibitory effect of anti-Tat antibodies on the replication of HIV could play an important regulatory role during infection in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7832634     DOI: 10.1007/bf01310790

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  37 in total

1.  Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication.

Authors:  M R Sadaie; R Mukhopadhyaya; Z N Benaissa; G N Pavlakis; F Wong-Staal
Journal:  AIDS Res Hum Retroviruses       Date:  1990-11       Impact factor: 2.205

2.  Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.

Authors:  R Gentz; C H Chen; C A Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

4.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner; R Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.

Authors:  B Ensoli; G Barillari; S Z Salahuddin; R C Gallo; F Wong-Staal
Journal:  Nature       Date:  1990-05-03       Impact factor: 49.962

6.  Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.

Authors:  P Reiss; F de Wolf; C L Kuiken; A de Ronde; J Dekker; C A Boucher; C Debouck; J M Lange; J Goudsmit
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

7.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.

Authors:  B Ensoli; L Buonaguro; G Barillari; V Fiorelli; R Gendelman; R A Morgan; P Wingfield; R C Gallo
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

10.  A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin.

Authors:  B E Vogel; S J Lee; A Hildebrand; W Craig; M D Pierschbacher; F Wong-Staal; E Ruoslahti
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

View more
  7 in total

1.  Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen.

Authors:  Emmanuel Moreau; Johan Hoebeke; Daniel Zagury; Sylviane Muller; Claude Desgranges
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade.

Authors:  Sonia Mediouni; Jennifer D Watkins; Michel Pierres; Angélique Bole; Erwann P Loret; Gilbert Baillat
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

3.  Identification of a highly conserved surface on Tat variants.

Authors:  Sonia Mediouni; Albert Darque; Isabelle Ravaux; Gilbert Baillat; Christian Devaux; Erwann P Loret
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

4.  Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein.

Authors:  Peter Silvera; Max W Richardson; Jack Greenhouse; Jake Yalley-Ogunro; Nigel Shaw; Jyotika Mirchandani; Kamel Khalili; Jean-Francois Zagury; Mark G Lewis; Jay Rappaport
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Antibody against human immunodeficiency virus type 1 (HIV-1) Tat protein may have influenced the progression of AIDS in HIV-1-infected hemophiliac patients.

Authors:  M C Re; G Furlini; M Vignoli; E Ramazzotti; G Zauli; M La Placa
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

Review 6.  Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  Giovanni Barillari; Barbara Ensoli
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

7.  HIV-1 protein Tat produces biphasic changes in NMDA-evoked increases in intracellular Ca2+ concentration via activation of Src kinase and nitric oxide signaling pathways.

Authors:  Kelly A Krogh; Nicole Wydeven; Kevin Wickman; Stanley A Thayer
Journal:  J Neurochem       Date:  2014-04-19       Impact factor: 5.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.